GCA
NUVA

Greenwood Capital Associates’s NuVasive, Inc. NUVA Stock Holding History

Greenwood Capital Associates’s Portfolio NUVA Stock Details NUVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-7,161
Closed -$355K – 210
2018
Q4 		$355K Buy
+7,161
New +$431K 0.09% 121

Other funds holding NUVA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Greenwood Capital Associates's NUVA Position: Q1 2019 in Review

Greenwood Capital Associates sold out of NuVasive, Inc. (NUVA) in Q1 2019, closing a stake of 7,161 shares — an estimated $355K sold.

Greenwood Capital Associates first reported a position in NUVA in Q4 2018 and held it in 1 quarter. The position peaked at $355K in Q4 2018. 255 funds tracked by Wall St. Rank hold NUVA as of Q1 2019.

  • Greenwood Capital Associates reported no remaining NuVasive, Inc. position as of Q1 2019 after selling out during the quarter.
  • Greenwood Capital Associates sold 7,161 NuVasive, Inc. shares in Q1 2019, an estimated $355K.
  • Greenwood Capital Associates first reported a position in NuVasive, Inc. in Q4 2018 and held it in 1 quarter.
  • Greenwood Capital Associates's NuVasive, Inc. position peaked at $355K in Q4 2018.
  • 255 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q1 2019.

Based on Greenwood Capital Associates's 13F filing for Q1 2019, filed 3 May 2019.